Neutel JM, Saunders E, Bakris GL, et al. 2005. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/ hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens (Greenwich), 7:578-86. Neutel JM, Smith DH, Silfani TN, et al. 2006. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension. J Hum Hypertens, 20:255-62. Neutel J, Smith D, Weber MA, et al. 2004. Use of olmesartan medoxomil- based treatment algorithm for hypertension control. J Clin Hypertens (Greenwich), 6:168-74. Pugsley M. 2006. A characterization of the molecular interactions of olmesartan (OLM) and telmisartan (TEL) with human angiotensin AT1 receptors [abstract]. American Society of Hypertension 21st Annual Scientific Meeting, New York, NY. Quan A, Chavanu K, Merkel J. 2006. A review of the efficacy of fixed- dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies. Am J Cardiovasc Drugs, 6:103-13. Ram CV. 2004. Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial- design studies. J Clin Hypertens (Greenwich), 6:569-77. Reyes A. 2002. Diuretics in the therapy of hypertension. J Hum Hypertens, 16(Suppl 1):S78-83. Olmesartan medoxomil/hydrochlorothiazide in hypertension Rump LC, Ambrosioni E, Burnier M, et al. 2006. Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension. J Hum Hypertens, 20:299-301. Sachse A, Verboom CN, Jager B. 2002. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension. J Hum Hypertens, 16:169-76. Schwocho LR, Masonson HN. 2001. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol, 41:515-27. Sellin L, Stegbauer J, Laeis P, et al. 2005. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. J Hypertens, 23:2083-92. Singer GM, Izhar M, Black HR. 2002. Goal-oriented hypertension management: translating clinical trials to practice. Hypertension, 40: 464-9. Swales JD. 1999. Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation- Regional and Global) project. Am Heart J, 138:231-7. Sweetman SC. 2005. Martindale: the complete drug reference. London: Pharmaceutical Press. Whitworth JA. 2003. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens, 21:1983-92. Vascular Health and Risk Management 2006:2(4) 409